Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization

Poxvirus prime-protein boost used in the RV144 trial remains the only immunization strategy shown to elicit a modest level of protection against HIV-1 acquisition in humans. Although neutralizing antibodies (NAb) were generated, they were against sensitive viruses, not the more resistant “tier 2” is...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Virol
Κύριοι συγγραφείς: Townsley, Samantha, Mohamed, Zeinab, Guo, Wenjin, McKenna, Jennifer, Cleveland, Brad, LaBranche, Celia, Beaumont, David, Shen, Xiaoying, Yates, Nicole L., Pinter, Abraham, Tomaras, Georgia D., Ferrari, Guido, Montefiori, David C., Hu, Shiu-Lok
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology 2016
Θέματα:
Vaccines and Antiviral Agents
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021413/
https://ncbi.nlm.nih.gov/pubmed/27440894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00853-16
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια